Citation: | YUE Yang, ZHENG Lu, YONG Dan, XU Hai. Relationships between expressions of Yes associated protein as well as carbonic anhydrase IX protein and occurrence as well as development of nasopharyngeal carcinoma[J]. Journal of Clinical Medicine in Practice, 2021, 25(6): 8-12. DOI: 10.7619/jcmp.20201930 |
[1] |
ZAMANIAN AZODI M, REZAEI TAVIRANI M, REZAEITAVIRANI M, et al. Nasopharyngeal carcinoma protein interaction mapping analysis via proteomic approaches[J]. Asian Pac J Cancer Prev, 2018, 19(3): 845-851. http://www.ncbi.nlm.nih.gov/pubmed/29582644
|
[2] |
FANG Y, XU C, WU P, et al. Prognostic role of C-reactive protein in patients with nasopharyngeal carcinoma: a meta-analysis and literature review[J]. Medicine(Baltimore), 2017, 96(45): e8463. http://pubmedcentralcanada.ca/pmcc/articles/PMC5690726/
|
[3] |
WANG M H, ZHOU X M, ZHANG M Y, et al. BMP2 promotes proliferation and invasion of nasopharyngeal carcinoma cells via m TORC1 pathway[J]. Aging(Albany NY), 2017, 9(4): 1326-1340. http://europepmc.org/articles/PMC5425130/
|
[4] |
AI P, LI Z P, JIANG Y, et al. Tumor microenvironment contributes to Epstein-Barr virus anti-nuclear antigen-1 antibody production in nasopharyngeal carcinoma[J]. Oncol Lett, 2017, 14(2): 2458-2462. doi: 10.3892/ol.2017.6461
|
[5] |
YE M, HUANG W, WU W W, et al. FM807, a curcumin analogue, shows potent antitumor effects in nasopharyngeal carcinoma cells by heat shock protein 90 inhibition[J]. Oncotarget, 2017, 8(9): 15364-15376. doi: 10.18632/oncotarget.14970
|
[6] |
吴孟超. 外科学[M]. 8版. 北京: 人民卫生出版社, 2013: 1-10.
|
[7] |
SHAN Y, YOU B, SHI S, et al. Hypoxia-induced matrix metalloproteinase-13 expression in exosomes from nasopharyngeal carcinoma enhances metastases[J]. Cell Death Dis, 2018, 9(3): 382. doi: 10.1038/s41419-018-0425-0
|
[8] |
JIANG C, LI L, LI J C, et al. Circulating EBV micro RNABART2-5p helps to diagnose nasopharyngeal carcinoma & screen for high risk individuals precisely[J]. Cancer Research, 2017, 77(13): 722-722.
|
[9] |
ZHANG W, ZHANG Y L, XI S M. Upregulation of lncRNAHAGLROS enhances the development of nasopharyngeal carcinoma via modulating mi R-100/ATG14 axis-mediated PI3K/AKT/m TOR signals[J]. Artif Cells Nanomed Biotechnol, 2019, 47(1): 3043-3052. doi: 10.1080/21691401.2019.1640233
|
[10] |
ZHANG Y Y, XU Z N. mi R-93 enhances cell proliferation by directly targeting CDKN1A in nasopharyngeal carcinoma[J]. Oncol Lett, 2018, 15(2): 1723-1727. http://www.ncbi.nlm.nih.gov/pubmed/29859935
|
[11] |
ZHOU J, WANG D, ZHENG J H, et al. Predictive value of excision repair cross-complementation group 1 protein in locoregionally advanced nasopharyngeal carcinomas receiving cisplatin-based concurrent chemoradiotherapy[J]. J Cancer Res Ther, 2018, 14(Supplement): S145-S151. http://europepmc.org/abstract/MED/29439312
|
[12] |
LEE C C, LIN M L, MENG M, et al. Galangin induces p53-independent S-phase arrest and apoptosis in human nasopharyngeal carcinoma cells through inhibiting PI3K-AKT signaling pathway[J]. Anticancer Res, 2018, 38(3): 1377-1389. http://europepmc.org/abstract/MED/29491062
|
[13] |
YU B B, LIN G X, LI L, et al. Cofilin-2 Acts as a marker for predicting radiotherapy response and is a potential therapeutic target in nasopharyngeal carcinoma[J]. Med Sci Monit, 2018, 24: 2317-2329. doi: 10.12659/MSM.909832
|
[14] |
LI L, ZHOU F J, LIN F Z, et al. Clinicopathologic characteristics of thyroid-like low-grade nasopharyngeal papillary adenocarcinoma: a case report[J]. Appl Immunohistochem Mol Morphol, 2019, 27(8): e81-e84. doi: 10.1097/PAI.0000000000000545
|
[15] |
CHUNG A K, OUYANG C N, LIU H, et al. Targeted sequencing of cancer-related genes in nasopharyngeal carcinoma identifies mutations in the TGF-βpathway[J]. Cancer Med, 2019, 8(11): 5116-5127. doi: 10.1002/cam4.2429
|
[16] |
MA W L, FENG L, ZHANG S S, et al. Induction of chemokine(C-C motif)ligand 5 by Epstein-Barr virus infection enhances tumor angiogenesis in nasopharyngeal carcinoma[J]. Cancer Sci, 2018, 109(5): 1710-1722. doi: 10.1111/cas.13584
|
[17] |
DOURTHE M E, BOLLE S, TEMAM S, et al. Childhood nasopharyngeal carcinoma: state-of-the-art, and questions for the future[J]. J Pediatr Hematol Oncol, 2018, 40(2): 85-92. doi: 10.1097/MPH.0000000000001054
|
[18] |
CAO C N, JIANG F, JIN Q F, et al. Paranasal sinus invasion in nasopharyngeal carcinoma after intensity-modulated radiotherapy[J]. Cancer Res Treat, 2019, 51(1): 73-79. doi: 10.4143/crt.2017.607
|